Leandro Vetcher
Fondatore presso Clade Therapeutics, Inc.
Profilo
Leandro Vetcher was the founder of Keclon SA (2011) and Green Pacific Biologicals, Inc. (2008), where he held the title of Chief Executive Officer & Director.
He is also the founder of Clade Therapeutics, Inc. Mr. Vetcher's former job was as a Researcher at Kosan Biosciences, Inc. Mr. Vetcher's education includes a graduate degree from The Trustees of Columbia University in The City of New York, an MBA degree from Massachusetts Institute of Technology, and an undergraduate degree from National University of Rosario.
Posizioni attive di Leandro Vetcher
| Società | Posizione | Inizio |
|---|---|---|
Clade Therapeutics, Inc.
 Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Leandro Vetcher
| Società | Posizione | Fine |
|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Keclon SA
 Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Fondatore | - |
Green Pacific Biologicals, Inc.
 Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Fondatore | - |
Formazione di Leandro Vetcher
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| National University of Rosario | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Green Pacific Biologicals, Inc.
Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Process Industries |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Keclon SA
Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Health Technology |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Leandro Vetcher
